110 related articles for article (PubMed ID: 25281493)
1. Adoption and impact of concurrent chemoradiation therapy for vaginal cancer: a National Cancer Data Base (NCDB) study.
Rajagopalan MS; Xu KM; Lin JF; Sukumvanich P; Krivak TC; Beriwal S
Gynecol Oncol; 2014 Dec; 135(3):495-502. PubMed ID: 25281493
[TBL] [Abstract][Full Text] [Related]
2. Patients Selected for Definitive Concurrent Chemoradiation at High-volume Facilities Achieve Improved Survival in Stage III Non-Small-Cell Lung Cancer.
Wang EH; Rutter CE; Corso CD; Decker RH; Wilson LD; Kim AW; Yu JB; Park HS
J Thorac Oncol; 2015 Jun; 10(6):937-43. PubMed ID: 25738221
[TBL] [Abstract][Full Text] [Related]
3. Patterns of care and brachytherapy boost utilization for vaginal cancer in the United States.
Rajagopalan MS; Xu KM; Lin J; Hansen K; Sukumvanich P; Krivak TC; Kelley JL; Beriwal S
Pract Radiat Oncol; 2015; 5(1):56-61. PubMed ID: 25413431
[TBL] [Abstract][Full Text] [Related]
4. The National Cancer Data Base report on cancer of the vagina.
Creasman WT; Phillips JL; Menck HR
Cancer; 1998 Sep; 83(5):1033-40. PubMed ID: 9731908
[TBL] [Abstract][Full Text] [Related]
5. HPV genotypes predict survival benefits from concurrent chemotherapy and radiation therapy in advanced squamous cell carcinoma of the cervix.
Wang CC; Lai CH; Huang YT; Chao A; Chou HH; Hong JH
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e499-506. PubMed ID: 22889667
[TBL] [Abstract][Full Text] [Related]
6. [Concurrent chemoradiotherapy followed by consolidation chemotherapy and sequential chemoradiotherapy for stage III non-small cell lung cancer: comparison in 93 patients].
Sun WZ; Song LP; Zhang YB; Ai T; Lu JL; Ren J; Gao Y
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):362-7. PubMed ID: 22445984
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of complete response in patients with muscle-invasive bladder cancer undergoing concurrent chemoradiotherapy.
Wu CE; Lin YC; Hong JH; Chuang CK; Pang ST; Liaw CC
Anticancer Res; 2013 Jun; 33(6):2605-10. PubMed ID: 23749915
[TBL] [Abstract][Full Text] [Related]
8. National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements.
Gill BS; Lin JF; Krivak TC; Sukumvanich P; Laskey RA; Ross MS; Lesnock JL; Beriwal S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1083-90. PubMed ID: 25216857
[TBL] [Abstract][Full Text] [Related]
9. Treatment results and prognostic factors for advanced squamous cell carcinoma of the larynx treated with concurrent chemoradiotherapy.
Taguchi T; Nishimura G; Takahashi M; Komatsu M; Sano D; Sakuma N; Arai Y; Yamashita Y; Shiono O; Hirama M; Sakuma Y; Ishitoya J; Hata M; Ogino I; Oridate N
Cancer Chemother Pharmacol; 2013 Oct; 72(4):837-43. PubMed ID: 23959463
[TBL] [Abstract][Full Text] [Related]
10. Outcomes and prognostic factors of cervical cancer after concurrent chemoradiation.
Kim TE; Park BJ; Kwack HS; Kwon JY; Kim JH; Yoon SC
J Obstet Gynaecol Res; 2012 Nov; 38(11):1315-20. PubMed ID: 22612778
[TBL] [Abstract][Full Text] [Related]
11. Outcomes and toxicities for the treatment of stage IVB cervical cancer.
Hwang JH; Lim MC; Seo SS; Kang S; Park SY; Kim JY
Arch Gynecol Obstet; 2012 Jun; 285(6):1685-93. PubMed ID: 22173823
[TBL] [Abstract][Full Text] [Related]
12. The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma.
Malaisrie SC; Hofstetter WL; Correa AM; Ajani JA; Komaki RR; Rice DC; Vaporciyan AA; Walsh GL; Roth JA; Wu TT; Swisher SG
Cancer; 2006 Sep; 107(5):967-74. PubMed ID: 16874819
[TBL] [Abstract][Full Text] [Related]
13. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.
Chen QY; Wen YF; Guo L; Liu H; Huang PY; Mo HY; Li NW; Xiang YQ; Luo DH; Qiu F; Sun R; Deng MQ; Chen MY; Hua YJ; Guo X; Cao KJ; Hong MH; Qian CN; Mai HQ
J Natl Cancer Inst; 2011 Dec; 103(23):1761-70. PubMed ID: 22056739
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in patients with advanced hypopharyngeal squamous cell carcinoma treated with concurrent chemoradiotherapy.
Krstevska V; Stojkovski I; Zafirova-Ivanovska B; Crvenkova S
J BUON; 2012; 17(2):327-36. PubMed ID: 22740214
[TBL] [Abstract][Full Text] [Related]
15. Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: A National Cancer Data Base (NCDB) analysis.
Gill BS; Bernard ME; Lin JF; Balasubramani GK; Rajagopalan MS; Sukumvanich P; Krivak TC; Olawaiye AB; Kelley JL; Beriwal S
Gynecol Oncol; 2015 Jun; 137(3):365-72. PubMed ID: 25868965
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors for survival in stage IIIA N2 NSCLC patients treated with neoadjuvant CCRT followed by surgery.
Lim HJ; Lee HY; Lee KS; Han J; Kwon OJ; Park K; Ahn YC; Kim BT; Shim YM
Cancer Chemother Pharmacol; 2015 Jan; 75(1):77-85. PubMed ID: 25374409
[TBL] [Abstract][Full Text] [Related]
17. The impact of brachytherapy boost and radiotherapy treatment duration on survival in patients with vaginal cancer treated with definitive chemoradiation.
Reshko LB; Gaskins JT; Metzinger DS; Todd SL; Eldredge-Hindy HB; Silva SR
Brachytherapy; 2021; 20(1):75-84. PubMed ID: 33008762
[TBL] [Abstract][Full Text] [Related]
18. Impact of facility volume on therapy and survival for locally advanced cervical cancer.
Lin JF; Berger JL; Krivak TC; Beriwal S; Chan JK; Sukumvanich P; Monk BJ; Richard SD
Gynecol Oncol; 2014 Feb; 132(2):416-22. PubMed ID: 24333361
[TBL] [Abstract][Full Text] [Related]
19. Primary squamous cell carcinoma of the vagina: prognostic factors, treatment patterns, and outcomes.
Hiniker SM; Roux A; Murphy JD; Harris JP; Tran PT; Kapp DS; Kidd EA
Gynecol Oncol; 2013 Nov; 131(2):380-5. PubMed ID: 23954572
[TBL] [Abstract][Full Text] [Related]
20. Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma.
Mabuchi S; Okazawa M; Matsuo K; Kawano M; Suzuki O; Miyatake T; Enomoto T; Kamiura S; Ogawa K; Kimura T
Gynecol Oncol; 2012 Oct; 127(1):114-20. PubMed ID: 22728518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]